Stuart S Leicht, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2898 Boones Creek Rd Ste 105, Johnson City, TN 37615 Phone: 423-262-0112 |
Donald Eugene Clemons, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1009 North State Of Franklin Access Road, Johnson City, TN 37604 Phone: 423-929-7546 Fax: 423-929-7968 |
George Beverly Winton, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1009 N State Of Franklin Access Road, Johnson City, TN 37604 Phone: 423-929-7546 Fax: 423-929-7968 |
James Richard Risney, PA Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1021 W Oakland Ave, Suite 102, Johnson City, TN 37604 Phone: 423-928-9014 Fax: 423-928-3559 |
Larry David Hudson, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1021 W Oakland Ave, Suite 102, Johnson City, TN 37604 Phone: 423-928-9014 Fax: 423-928-9014 |
Timothy Lee Gardner, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1009 N State Of Franklin Access Rd, Johnson City, TN 37604 Phone: 423-929-7546 Fax: 423-929-7968 |
Robert John Clemons, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1009 North State Of Franklin Access Road, Johnson City, TN 37604 Phone: 423-929-7546 Fax: 423-929-7968 |
Paul Michael Benson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1009 North State Of Franklin Access Road, Johnson City, TN 37604 Phone: 423-929-7546 Fax: 423-929-7968 |
News Archive
"Yemen's populist uprising and the political crisis that followed have pushed the country to the brink of a humanitarian emergency, according to the United Nations and aid agencies," the Washington Post reports, noting that "children have been hit especially hard."
Tangent Inc., today announced the Medix T22, a medical grade, point-of-care terminal with a sharp and clear 22-inch wide-screen TFD display.
AbbVie released preliminary results from an ongoing Phase I study with ABT-414, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody drug conjugate, in combination with temozolomide, which showed four objective responses, including one complete response, in patients with recurrent or unresectable glioblastoma multiforme.
Patients with terminal cancer face difficult decisions. What treatment options support their goals? When is it reasonable to discontinue care? A study published in the American Journal of Geriatric Psychiatry shows that these patients may be less competent to make these decisions than their doctors think.
› Verified 5 days ago